Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Amano

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Internal Medicine (Tokyo, Japan)|October 4, 2006
Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapyKoichi Amano
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 31, 2018
[Diagnostic (Classification) Criteria and Treatment Guidelines of Collagen-vascular Diseases: Hos to Use and Cautions on Applying Them for General Physicians. Topics: V. Giant Cell Arteritis]Koichi Amano
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 24, 2007
[Anti-TNF-alpha chimeric antibody (infliximab)]Koichi Amano
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 14, 2009
[Biological agents]Koichi Amano
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Infliximab for therapy of rheumatoid arthritis]Koichi Amano
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 4, 2003
[Systemic corticosteroids in rheumatoid arthritis: to use or not to use?]Koichi Amano
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 22, 2013
[Tocilizumab]Koichi Amano
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 11, 2012
[Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment 2. Antirheumatic agents, 2) biological agents]Koichi Amano
Clinical Calcium|November 27, 2015
[Control of bone and cartilage lesions in rheumatoid arthritis with TNF inhibitors]Koichi Amano
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 20, 2011
[Treatment of rheumatic diseases: current status and future prospective. Topics: III. Biological drugs; 1. TNF inhibitors]Koichi Amano
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Internal Medicine (Tokyo, Japan)|October 4, 2006
Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapyKoichi Amano
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 31, 2018
[Diagnostic (Classification) Criteria and Treatment Guidelines of Collagen-vascular Diseases: Hos to Use and Cautions on Applying Them for General Physicians. Topics: V. Giant Cell Arteritis]Koichi Amano
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 24, 2007
[Anti-TNF-alpha chimeric antibody (infliximab)]Koichi Amano
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 14, 2009
[Biological agents]Koichi Amano
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 2005
[Infliximab for therapy of rheumatoid arthritis]Koichi Amano
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 4, 2003
[Systemic corticosteroids in rheumatoid arthritis: to use or not to use?]Koichi Amano
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 22, 2013
[Tocilizumab]Koichi Amano
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 11, 2012
[Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment 2. Antirheumatic agents, 2) biological agents]Koichi Amano
Clinical Calcium|November 27, 2015
[Control of bone and cartilage lesions in rheumatoid arthritis with TNF inhibitors]Koichi Amano
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 20, 2011
[Treatment of rheumatic diseases: current status and future prospective. Topics: III. Biological drugs; 1. TNF inhibitors]Koichi Amano
Pageof 15